Skip to main content
eBioMedicine logoLink to eBioMedicine
. 2018 Aug 23;35:405. doi: 10.1016/j.ebiom.2018.08.030

Corrigendum to Commentary “Negative Impact of CMV and BKV Infections on Kidney-Allograft Function at 1-Year Post-Transplantation: Can it Be Changed by Modifying Immunosuppression?” [EBioMedicine DOI: https://doi.org/10.1016/j.ebiom.2018.07.032]

PMCID: PMC6157288  PMID: 30146343

The authors wish to point out that some of the numbers presented in this commentary do not correspond exactly to those in the original manuscript. The final version of the original article excluded one sample, leading to minor changes to some of the statistics. Unfortunately, an earlier version of the original study was used to write this commentary.

The corrections are detailed below:

  • -

    541 kidney-transplant recipients → 540 kidney-transplant recipients

  • -

    3716 serum samples → 3715 serum samples

  • -

    20.1% of patients had prolonged BKV viremia → 20.2% of patients had prolonged BKV viremia

  • -

    7.21% of patients → 7.22% of patients

  • -

    6.47% of patients → 6.48% of patients

  • -

    EBV viremia was detected at least once in 20.1% of patients → EBV viremia was detected at least once in 20.2% of patients

  • -

    6.83% of patients → 6.85% of patients

  • -

    6.65% of patients → 6.67% of patients

  • -

    In the reference section, “Wittenbrick” should say “Wittenbrink”

  • -

    Where it says: “13.9 8.9 mL/min/1.73m2”, it should say “13.9 mL/min/1.73 m2”.

These small differences do not alter the conclusions of the commentary.


Articles from EBioMedicine are provided here courtesy of Elsevier

RESOURCES